| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 44 |
| 1 | ESOMEPRAZOLE MAGNESIUM | 34 |
| 2 | CAPECITABINE | 31 |
| 3 | CISPLATIN | 25 |
| 4 | OMEPRAZOLE | 22 |
| 5 | PACLITAXEL | 22 |
| 6 | OXALIPLATIN | 21 |
| 7 | ADALIMUMAB | 18 |
| 8 | TRASTUZUMAB | 18 |
| 9 | FLUOROURACIL | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METEX | 1 | 0.0026 |
| 1 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 2 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 3 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE | 1 | 0.0018 |
| 4 | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE | 1 | 0.0017 |
| 5 | RAMUCIRUMAB | 10 | 0.0016 |
| 6 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 7 | PEMIGATINIB | 1 | 0.0012 |
| 8 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 9 | FLUTAMIDE | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 47 |
| 1 | Platinum-based Drug [EPC] | 47 |
| 2 | Corticosteroid [EPC] | 41 |
| 3 | Proton Pump Inhibitor [EPC] | 33 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 5 | Microtubule Inhibitor [EPC] | 28 |
| 6 | Opioid Agonist [EPC] | 22 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 20 |
| 8 | Benzodiazepine [EPC] | 18 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 10 | 0.0016 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 2 | Bismuth [EPC] | 3 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 5 | Stimulant Laxative [EPC] | 5 | 0.0003 |
| 6 | Glinide [EPC] | 3 | 0.0003 |
| 7 | Aluminum Complex [EPC] | 7 | 0.0003 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 20 | 0.0003 |